Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Irritable Bowel Syndrome, August 2022

Free Subscription


Abstracts

Retrieve all available abstracts of the following 119 articles:
HTML format


 

Single Articles

  1. WU J, Li T, Mao G, Cha X, et al
    The involvement of Pellino-1 downregulation in the modulation of visceral hypersensitivity via the TLR4/NF-kappaB pathway in the rat fastigial nucleus.
    Neurosci Lett. 2022 Jul 25:136815. doi: 10.1016/j.neulet.2022.136815.
    PubMed    
    Abstract available

  2. XIAO D, Zhang Y, Chen W, Xuan J, et al
    Correction to: Cost-Effectiveness of Linaclotide Compared to Osmotic Laxatives in the Treatment of Irritable Bowel Syndrome with Constipation in China.
    Adv Ther. 2022 Jul 28. pii: 10.1007/s12325-022-02236.
    PubMed    


  3. DARWEISH E, Marzouk HM, Fayez YM, Eissa MS, et al
    Advanced spectrophotometric resolution techniques for spectrally overlapping spasmolytic binary mixture along with Dichloroaniline as a toxic impurity: Application to content uniformity testing.
    J AOAC Int. 2022 Jul 28. pii: 6651096. doi: 10.1093.
    PubMed    
    Abstract available

  4. LIU Y, Zhang S, Wu X, Li Q, et al
    Instant messaging client gives the opportunity to recognize gut microbiota and dysbiosis-related disease: An investigation study on WeChat APP.
    Digit Health. 2022;8:20552076221115018.
    PubMed    
    Abstract available

  5. DE PALMA G, Shimbori C, Reed DE, Yu Y, et al
    Histamine production by the gut microbiota induces visceral hyperalgesia through histamine 4 receptor signaling in mice.
    Sci Transl Med. 2022;14:eabj1895.
    PubMed    
    Abstract available

  6. LEONI C, Giorgio V, Stella G, Onesimo R, et al
    Prevalence of gastrointestinal disorders in individuals with RASopathies: May RAS/MAP/ERK pathway dysfunctions be a model of neuropathic pain and visceral hypersensitivity?
    Am J Med Genet A. 2022 Jul 27. doi: 10.1002/ajmg.a.62917.
    PubMed    
    Abstract available

  7. WILS P, Caron B, D'Amico F, Danese S, et al
    Abdominal Pain in Inflammatory Bowel Diseases: A Clinical Challenge.
    J Clin Med. 2022;11.
    PubMed    
    Abstract available

  8. JIA W, Liang H, Wang L, Sun M, et al
    Associations between Abnormal Eating Styles and Irritable Bowel Syndrome: A Cross-Sectional Study among Medical School Students.
    Nutrients. 2022;14.
    PubMed    
    Abstract available

  9. ZIMMERMANN J, Longin FH, Schweinlin A, Basrai M, et al
    No Difference in Tolerance between Wheat and Spelt Bread in Patients with Suspected Non-Celiac Wheat Sensitivity.
    Nutrients. 2022;14.
    PubMed    
    Abstract available

  10. PENG S, Ling X, Rui W, Jin X, et al
    LMWP (S3-3) from the Larvae of Musca domestica Alleviate D-IBS by Adjusting the Gut Microbiota.
    Molecules. 2022;27.
    PubMed    
    Abstract available

  11. MAZZAWI T
    Gut Microbiota Manipulation in Irritable Bowel Syndrome.
    Microorganisms. 2022;10.
    PubMed    
    Abstract available

  12. BASSOTTI G
    Irritable Bowel Syndrome: A Multifaceted World Still to Discover.
    J Clin Med. 2022;11.
    PubMed    
    Abstract available

  13. CHOI HG, Kang HS, Lim H, Kim JH, et al
    Changes in the Incidence Rates of Gastrointestinal Diseases Due to the COVID-19 Pandemic in South Korea: A Long-Term Perspective.
    J Pers Med. 2022;12.
    PubMed    
    Abstract available

  14. BLASS I, Sahar T, Shraibman A, Ofer D, et al
    Revisiting the Risk Factors for Endometriosis: A Machine Learning Approach.
    J Pers Med. 2022;12.
    PubMed    
    Abstract available

  15. LASSMANN L, Pollis M, Zoltowska A, Manfredini D, et al
    Gut Bless Your Pain-Roles of the Gut Microbiota, Sleep, and Melatonin in Chronic Orofacial Pain and Depression.
    Biomedicines. 2022;10.
    PubMed    
    Abstract available

  16. WAN Y, Zhang B
    The Impact of Zinc and Zinc Homeostasis on the Intestinal Mucosal Barrier and Intestinal Diseases.
    Biomolecules. 2022;12.
    PubMed    
    Abstract available

  17. KUSHLINSKII NE, Gershtein ES, Zybina NN, Tsarapaev PV, et al
    Blood Serum Zonulin in Colorectal Cancer, Autoimmune Bowel Diseases, and Irritable Bowel Syndrome.
    Bull Exp Biol Med. 2022;173:376-379.
    PubMed    
    Abstract available

  18. ZHOU ZX, Ma HF, Yang YC, Chen JT, et al
    [Effect of electroacupuncture on colonic motility and RhoA and ROCK protein expression in IBS-D rats].
    Zhen Ci Yan Jiu. 2022;47:611-6.
    PubMed    
    Abstract available

  19. YU SJ, Lee HS, Gung HJ, Kim JS, et al
    Efficacy of a Restrictive Diet in Irritable Bowel Syndrome: A Systematic Review and Network Meta-analysis.
    Korean J Gastroenterol. 2022;80:6-16.
    PubMed    
    Abstract available

  20. DAS BB, Panda AK, Patra MP, Nayak K, et al
    Study on the Role of Gastrointestinal Parasite in Irritable Bowel Syndrome Patients in a Tribal Region of India.
    Cureus. 2022;14:e26091.
    PubMed    
    Abstract available

  21. ELSAYGH H, Alhafez I, Jaber M, Al-Rasheed M, et al
    A Literature Review of Major Clinical Trials That Contributed to Treatment Protocols of Irritable Bowel Syndrome With Diarrhea.
    Cureus. 2022;14:e26092.
    PubMed    
    Abstract available

  22. GONG Z, Yang Q, Wang Y, Weng X, et al
    Pharmacokinetic Differences of Wuji Pill Components in Normal and Chronic Visceral Hypersensitivity Irritable Bowel Syndrome Rats Attributable to Changes in Tight Junction and Transporters.
    Front Pharmacol. 2022;13:948678.
    PubMed    
    Abstract available

  23. MOSHIREE B, Heidelbaugh JJ, Sayuk GS
    A Narrative Review of Irritable Bowel Syndrome with Diarrhea: A Primer for Primary Care Providers.
    Adv Ther. 2022 Jul 22. pii: 10.1007/s12325-022-02224.
    PubMed    
    Abstract available

  24. SUGAYA N, Tomita Y, Funaba M, Iida H, et al
    Validity and reliability of the Japanese versions of cognitive and behavioral scales for irritable bowel syndrome.
    Biopsychosoc Med. 2022;16:15.
    PubMed    
    Abstract available

  25. WHITE L
    Like clockwork? (Re)imagining rhythms and routines when living with irritable bowel syndrome (IBS).
    Sociol Health Illn. 2022 Aug 5. doi: 10.1111/1467-9566.13504.
    PubMed    
    Abstract available

  26. ROZENTAL A, Sorman K, Ojala O, Jangard S, et al
    Mental health in individuals with self-reported psychiatric symptoms during the COVID-19 pandemic: Baseline data from a swedish longitudinal cohort study.
    Front Psychiatry. 2022;13:933858.
    PubMed    
    Abstract available


  27. Lasting Effects of Helicobacter pylori Infection on the Microbial Communities of Patients with and without Small Intestinal Bacterial Overgrowth.
    New Microbiol. 2022;45:193-198.
    PubMed    
    Abstract available

  28. ZHOU Y, Zhang F, Mao L, Feng T, et al
    Bifico relieves irritable bowel syndrome by regulating gut microbiota dysbiosis and inflammatory cytokines.
    Eur J Nutr. 2022 Aug 2. pii: 10.1007/s00394-022-02958.
    PubMed    
    Abstract available

  29. BAZHANOV S, Lan Y, Gonzales K, Winston JH, et al
    Fetal corticosterone exposure leads to enhanced visceral hypersensitivity and is associated with down-regulation of placental 11-beta-steriod dehydrogenase 2.
    Am J Physiol Gastrointest Liver Physiol. 2022.
    PubMed    
    Abstract available

  30. BROUNS F, Geisslitz S, Guzman C, Ikeda TM, et al
    Do ancient wheats contain less gluten than modern bread wheat, in favour of better health?
    Nutr Bull. 2022;47:157-167.
    PubMed    
    Abstract available

  31. DONG Z, Zhan T, Sun H, Wang J, et al
    Astrocytic ERK/STAT1 signaling contributes to maintenance of stress-related visceral hypersensitivity in rats.
    J Pain. 2022 Jul 29. pii: S1526-5900(22)00365.
    PubMed    
    Abstract available

  32. ZHANG G, Zhang T, Cao Z, Tao Z, et al
    Effects and Mechanisms of Acupuncture on Diarrhea-Predominant Irritable Bowel Syndrome: A Systematic Review.
    Front Neurosci. 2022;16:918701.
    PubMed    
    Abstract available

  33. SHI JT, Zhang Y, She Y, Goyal H, et al
    Diagnostic Utility of Non-invasive Tests for Inflammatory Bowel Disease: An Umbrella Review.
    Front Med (Lausanne). 2022;9:920732.
    PubMed    
    Abstract available

  34. ENGEL F, Stadnitski T, Stroe-Kunold E, Berens S, et al
    Temporal Relationships Between Abdominal Pain, Psychological Distress and Coping in Patients With IBS - A Time Series Approach.
    Front Psychiatry. 2022;13:768134.
    PubMed    
    Abstract available

  35. HOU Z, Ding Q, Li Y, Zhao Z, et al
    Intestinal epithelial beta Klotho is a critical protective factor in alcohol-induced intestinal barrier dysfunction and liver injury.
    EBioMedicine. 2022;82:104181.
    PubMed    
    Abstract available

  36. SANDERS AE, Weatherspoon ED, Ehrmann BM, Soma PS, et al
    Circulating polyunsaturated fatty acids, pressure pain thresholds, and nociplastic pain conditions.
    Prostaglandins Leukot Essent Fatty Acids. 2022;184:102476.
    PubMed    
    Abstract available

  37. POLGAR A, Szalka B, Molnar T, Vassanyi I, et al
    A mobilapplikacioval tamogatott alacsony-FODMAP-etrend a funkcionalis gastrointestinalis es a gyulladasos belbetegsegek kezeleseben.
    Orv Hetil. 2022;163:1224-1230.
    PubMed    
    Abstract available

  38. EJTEHADI F, Anbardar MH, Imanieh MH, Niknam R, et al
    Organic colonic lesions in patients with irritable bowel syndrome: A comparative study.
    Rev Gastroenterol Mex (Engl Ed). 2022 Jul 26. pii: S2255-534X(22)00094.
    PubMed    
    Abstract available

  39. SHIMBORI C, De Palma G, Baerg L, Lu J, et al
    Gut bacteria interact directly with colonic mast cells in a humanized mouse model of IBS.
    Gut Microbes. 2022;14:2105095.
    PubMed    
    Abstract available

  40. MAHENDRA RAJ S, Ravindran S, Kaur M, Braganza MC, et al
    Duodenal eosinophilia is associated with symptomatic erosive gastro-oesophageal reflux disease, presence of co-morbidities, and ethnicity but not undifferentiated functional dyspepsia: A retrospective Malaysian study.
    Med J Malaysia. 2022;77:494-499.
    PubMed    
    Abstract available

  41. DOLNIK O, Becker S
    Assembly and transport of filovirus nucleocapsids.
    PLoS Pathog. 2022;18:e1010616.
    PubMed    
    Abstract available

  42. IZADPARAST F, Riahi-Zajani B, Yarmohammadi F, Hayes AW, et al
    Protective effect of berberine against LPS-induced injury in the intestine: a review.
    Cell Cycle. 2022 Jul 19:1-14. doi: 10.1080/15384101.2022.2100682.
    PubMed    
    Abstract available

  43. SANGALLI L, Miller CS
    Low-dose naltrexone for treatment of burning mouth syndrome.
    Oral Surg Oral Med Oral Pathol Oral Radiol. 2022.
    PubMed    
    Abstract available

  44. KIM JH, Yi DY, Lee YM, Choi YJ, et al
    Association between body mass index and fecal calprotectin levels in children and adolescents with irritable bowel syndrome.
    Medicine (Baltimore). 2022;101:e29968.
    PubMed    
    Abstract available

  45. XU R, Liu X, Tian M, Chen D, et al
    Atractylodes-I overcomes the oxidative stress-induced colonic mucosal epithelial cells dysfunction to prevent irritable bowel syndrome via modulating the miR-34a-5p-LDHA signaling pathway.
    Curr Mol Med. 2022 Aug 11. pii: CMM-EPUB-125439.
    PubMed    
    Abstract available

  46. BISCHOFF SC, Barazzoni R, Busetto L, Campmans-Kuijpers M, et al
    European guideline on obesity care in patients with gastrointestinal and liver diseases - Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline.
    United European Gastroenterol J. 2022 Aug 12. doi: 10.1002/ueg2.12280.
    PubMed    
    Abstract available

  47. NABI MY, Nauhria S, Reel M, Londono S, et al
    Endometriosis and irritable bowel syndrome: A systematic review and meta-analyses.
    Front Med (Lausanne). 2022;9:914356.
    PubMed    
    Abstract available

  48. MATTILA J, Stenholm T, Loyttyniemi E, Koffert J, et al
    Predictive Markers of Crohn's Disease in Small Bowel Capsule Endoscopy: A Retrospective Study of Small Bowel Capsule Endoscopy.
    J Clin Med. 2022;11.
    PubMed    
    Abstract available

  49. KRISHNACHAITANYA SS, Liu M, Fujise K, Li Q, et al
    MicroRNAs in Inflammatory Bowel Disease and Its Complications.
    Int J Mol Sci. 2022;23.
    PubMed    
    Abstract available

  50. MEADE E, Garvey M
    The Role of Neuro-Immune Interaction in Chronic Pain Conditions; Functional Somatic Syndrome, Neurogenic Inflammation, and Peripheral Neuropathy.
    Int J Mol Sci. 2022;23.
    PubMed    
    Abstract available

  51. KOVACS DB, Szekely A, Hubai AG, Palsson O, et al
    Prevalence, epidemiology and associated healthcare burden of Rome IV irritable bowel syndrome and functional dyspepsia in the adult population of Gibraltar.
    BMJ Open Gastroenterol. 2022;9.
    PubMed    
    Abstract available

  52. NABAVI-RAD A, Sadeghi A, Asadzadeh Aghdaei H, Yadegar A, et al
    The double-edged sword of probiotic supplementation on gut microbiota structure in Helicobacter pylori management.
    Gut Microbes. 2022;14:2108655.
    PubMed    
    Abstract available

  53. RYAN A, Healey M, Cheng C, Dior U, et al
    Central sensitisation in pelvic pain: A cohort study.
    Aust N Z J Obstet Gynaecol. 2022 Aug 11. doi: 10.1111/ajo.13596.
    PubMed    
    Abstract available

  54. ZHOU Q, Verne GN
    Epigenetic modulation of visceral nociception.
    Neurogastroenterol Motil. 2022 Aug 10:e14443. doi: 10.1111/nmo.14443.
    PubMed    
    Abstract available

  55. CAMILLERI M, Zhernakova A, Bozzarelli I, D'Amato M, et al
    Genetics of irritable bowel syndrome: shifting gear via biobank-scale studies.
    Nat Rev Gastroenterol Hepatol. 2022 Aug 10. pii: 10.1038/s41575-022-00662.
    PubMed    
    Abstract available

  56. EFFENDI SSW, Ng IS
    Prospective and challenges of live bacterial therapeutics from a superhero Escherichia coli Nissle 1917.
    Crit Rev Microbiol. 2022 Aug 10:1-17. doi: 10.1080/1040841X.2022.2109405.
    PubMed    
    Abstract available

  57. DEMIROREN K, Guney B, Bostanci M, Ekici D, et al
    A Comparison Between Rome III and Rome IV Criteria in Children with Chronic Abdominal Pain: A Prospective Observational Cohort Study.
    Turk J Gastroenterol. 2022 Aug 10. doi: 10.5152/tjg.2022.21893.
    PubMed    
    Abstract available

  58. CHAN WW, Grover M
    The COVID-19 Pandemic and Postinfection Irritable Bowel Syndrome: What Lies Ahead for Gastroenterologists.
    Clin Gastroenterol Hepatol. 2022 Aug 6. pii: S1542-3565(22)00601.
    PubMed    


  59. MA W, Drew DA, Staller K
    The Gut Microbiome and Colonic Motility Disorders: A Practical Framework for the Gastroenterologist.
    Curr Gastroenterol Rep. 2022 Aug 9. pii: 10.1007/s11894-022-00847.
    PubMed    
    Abstract available

  60. BOINPALLY R, McGeeney D, Kaczynski E, Weissman D, et al
    An Open-Label Study to Evaluate the Effect of Eluxadoline on the Single-Dose Pharmacokinetics of Midazolam in Healthy Participants.
    Clin Pharmacol Drug Dev. 2022 Aug 8. doi: 10.1002/cpdd.1150.
    PubMed    
    Abstract available

  61. BILAL M, Ashraf S, Zhao X
    Dietary Component-Induced Inflammation and Its Amelioration by Prebiotics, Probiotics, and Synbiotics.
    Front Nutr. 2022;9:931458.
    PubMed    
    Abstract available

  62. ZHENG Z, Tang J, Hu Y, Zhang W, et al
    Role of gut microbiota-derived signals in the regulation of gastrointestinal motility.
    Front Med (Lausanne). 2022;9:961703.
    PubMed    
    Abstract available

  63. HUANG IH, Schol J, Khatun R, Carbone F, et al
    Worldwide prevalence and burden of gastroparesis-like symptoms as defined by the United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis.
    United European Gastroenterol J. 2022 Aug 19. doi: 10.1002/ueg2.12289.
    PubMed    
    Abstract available

  64. HUSEIN DM, Rizk S, Hoter AU, Wanes D, et al
    Severe pathogenic variants of intestinal sucrase-isomaltase interact avidly with the wild type enzyme and negatively impact its function and trafficking.
    Biochim Biophys Acta Mol Basis Dis. 2022 Aug 16:166523.
    PubMed    
    Abstract available

  65. JADALLAH KA, Khatatbeh MM, Sarsak EW, Sweidan AN, et al
    Irritable bowel syndrome and its associated factors among Jordanian medical students: A cross-sectional study.
    Medicine (Baltimore). 2022;101:e30134.
    PubMed    
    Abstract available

  66. BILBAO A, Spanagel R
    Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications.
    BMC Med. 2022;20:259.
    PubMed    
    Abstract available

  67. YU C, Tovar S, Shi J, Padilla A, et al
    SATISFACTION WITH TELEHEALTH AMONG PATIENTS WITH IRRITABLE BOWEL SYNDROME DURING COVID-19: CROSS-SECTIONAL SURVEY FINDINGS.
    Clin Transl Gastroenterol. 2022 Aug 18. pii: 01720094-990000000-00079.
    PubMed    
    Abstract available

  68. MOUREY F, Decherf A, Jeanne JF, Clement-Ziza M, et al
    Saccharomyces cerevisiae I-3856 in irritable bowel syndrome with predominant constipation.
    World J Gastroenterol. 2022;28:2509-2522.
    PubMed    
    Abstract available

  69. DONG LW, Ma ZC, Fu J, Huang BL, et al
    Upregulated adenosine 2A receptor accelerates post-infectious irritable bowel syndrome by promoting CD4+ T cells' T helper 17 polarization.
    World J Gastroenterol. 2022;28:2955-2967.
    PubMed    
    Abstract available

  70. CHURA-CHAMBI RM, Farah CS, Morganti L
    Human growth hormone inclusion bodies present native-like secondary and tertiary structures which can be preserved by mild solubilization for refolding.
    Microb Cell Fact. 2022;21:164.
    PubMed    
    Abstract available

  71. LACY BE, King J, Shortino D, Schaumburg C, et al
    Efficacy and safety of vibegron for the treatment of irritable bowel syndrome in women: Results of a randomized, double-blind, placebo-controlled phase 2 trial.
    Neurogastroenterol Motil. 2022 Aug 16:e14448. doi: 10.1111/nmo.14448.
    PubMed    
    Abstract available

  72. ROACH K, Roberts J
    A comprehensive summary of disease variants implicated in metal allergy.
    J Toxicol Environ Health B Crit Rev. 2022.
    PubMed    
    Abstract available

  73. ADAM F, Jouet P, Sabate JM, Perrot S, et al
    The thermal grill illusion of pain in chronic pain patients: a clinical marker of central sensitization?
    Pain. 2022 Aug 15. pii: 00006396-990000000-00151.
    PubMed    
    Abstract available

  74. BISCHOFF SC, Barazzoni R, Busetto L, Campmans-Kuijpers M, et al
    European guideline on obesity care in patients with gastrointestinal and liver diseases - Joint ESPEN/UEG guideline.
    Clin Nutr. 2022 Aug 11. pii: S0261-5614(22)00239.
    PubMed    
    Abstract available

  75. OHLSSON B
    Extraintestinal manifestations in irritable bowel syndrome: A systematic review.
    Therap Adv Gastroenterol. 2022;15:17562848221114558.
    PubMed    
    Abstract available

  76. SCHELL KR, Fernandes KE, Shanahan E, Wilson I, et al
    The Potential of Honey as a Prebiotic Food to Re-engineer the Gut Microbiome Toward a Healthy State.
    Front Nutr. 2022;9:957932.
    PubMed    
    Abstract available

  77. HE S, Lin Q, Huang J, Zheng L, et al
    Effect and Mechanism of Flavored Tongxie Yaofang Decoction for Diarrheal Irritable Bowel Syndrome under Intestinal Microecology.
    Evid Based Complement Alternat Med. 2022;2022:3904571.
    PubMed    
    Abstract available

  78. WANG J, Duan G, Zhan T, Dong Z, et al
    Upregulation of Netrin-1 in the hippocampus mediates the formation of visceral hypersensitivity induced by maternal separation.
    Front Mol Neurosci. 2022;15:908911.
    PubMed    
    Abstract available

  79. SHIN A, Xu H, Imperiale TF
    The Prevalence, Humanistic Burden, and Healthcare Impact of Irritable Bowel Syndrome (IBS) Among United States Veterans.
    Clin Gastroenterol Hepatol. 2022 Aug 11. pii: S1542-3565(22)00769.
    PubMed    
    Abstract available

  80. ZHONG P, Zhou J, Fan YT, Guo MF, et al
    Co-existing polysaccharides affect the systemic exposure of major bioactive ingredients in Chang-Kang-Fang, a multi-herb prescription for treatment of irritable bowel syndrome.
    J Ethnopharmacol. 2022;298:115601.
    PubMed    
    Abstract available

  81. FU Q, Song T, Ma X, Cui J, et al
    Research progress on the relationship between intestinal microecology and intestinal bowel disease.
    Animal Model Exp Med. 2022 Aug 12. doi: 10.1002/ame2.12262.
    PubMed    
    Abstract available

  82. BERTUCCIOLI A, Cardinali M, Di Pierro F, Zonzini GB, et al
    Ketogenic and Low FODMAP Diet in Therapeutic Management of a Young Autistic Patient with Epilepsy and Dysmetabolism Poorly Responsive to Therapies: Clinical Response and Effects of Intestinal Microbiota.
    Int J Mol Sci. 2022;23.
    PubMed    
    Abstract available

  83. MOHAMED OA, Samir S, Omar H, Hassan EA, et al
    Lab-scale Preparation of Recombinant Human Insulin-like Growth Factor-1 in Escherichia coli and its Potential Safety on Normal Human Lung Cell Line.
    Recent Pat Biotechnol. 2022;16:266-280.
    PubMed    
    Abstract available

  84. WEI X, Wen Y, Wei Y, Liang X, et al
    External therapy of traditional Chinese medicine for treating irritable bowel syndrome with diarrhea: A systematic review and meta-analysis.
    Front Med (Lausanne). 2022;9:940328.
    PubMed    
    Abstract available

  85. MROZ M, Czub M, Brytek-Matera A
    Heart Rate Variability-An Index of the Efficacy of Complementary Therapies in Irritable Bowel Syndrome: A Systematic Review.
    Nutrients. 2022;14.
    PubMed    
    Abstract available

  86. WIELGOSZ-GROCHOWSKA JP, Domanski N, Drywien ME
    Efficacy of an Irritable Bowel Syndrome Diet in the Treatment of Small Intestinal Bacterial Overgrowth: A Narrative Review.
    Nutrients. 2022;14.
    PubMed    
    Abstract available

  87. WANG Z, Liu Y, Peng Y, Peng L, et al
    Helicobacterpylori Infection-A Risk Factor for Irritable Bowel Syndrome? An Updated Systematic Review and Meta-Analysis.
    Medicina (Kaunas). 2022;58.
    PubMed    
    Abstract available

  88. CHERRY RN, Blanchard SS, Chogle A, Santucci NR, et al
    Herbal Approaches to Pediatric Functional Abdominal Pain.
    Children (Basel). 2022;9.
    PubMed    
    Abstract available

  89. JOSHI V, Chhonker YS, Soni D, Cunningham KC, et al
    A Selective and Sensitive LC-MS/MS Method for Quantitation of Indole in Mouse Serum and Tissues.
    Metabolites. 2022;12.
    PubMed    
    Abstract available

  90. CHOUDHURY A, Tariq R, Jena A, Vesely EK, et al
    Gastrointestinal manifestations of long COVID: A systematic review and meta-analysis.
    Therap Adv Gastroenterol. 2022;15:17562848221118403.
    PubMed    
    Abstract available

  91. CHEN HY, Liu J, Weng DZ, Yan L, et al
    Ameliorative effect and mechanism of Si-Ni-San on chronic stress-induced diarrhea-irritable bowel syndrome in rats.
    Front Pharmacol. 2022;13:940463.
    PubMed    
    Abstract available

  92. BARAZANJI N, Paul Hamilton J, Icenhour A, Simon RA, et al
    Irritable bowel syndrome in women: Association between decreased insular subregion volumes and gastrointestinal symptoms.
    Neuroimage Clin. 2022;35:103128.
    PubMed    
    Abstract available

  93. RIBEIRO M, Ferreira D, Siopa J, Rodriguez-Quijano M, et al
    Natural Variation in the Content and Degree of Polymerization of Fructans in Wheat: Potential for Selection of Genotypes with Beneficial Health Composition.
    J Agric Food Chem. 2022 Aug 24. doi: 10.1021/acs.jafc.2c03686.
    PubMed    
    Abstract available

  94. MICHAEL R, Bettina V, Eckehard L
    Functional gastrointestinal disorders in children: Effectivity, safety, and tolerability of the herbal preparation STW-5 (Iberogast(R)) in general practice.
    Complement Ther Med. 2022 Aug 20:102873. doi: 10.1016/j.ctim.2022.102873.
    PubMed    
    Abstract available

  95. NAZAREWSKA A, Lewandowski K, Kaniewska M, Rosolowski M, et al
    Irritable bowel syndrome following COVID-19: underestimated consequence of infection with SARS-CoV-2.
    Pol Arch Intern Med. 2022 Aug 23. doi: 10.20452/pamw.16323.
    PubMed    
    Abstract available

  96. LI YC, Wang Q, Li MG, Hu SF, et al
    A paraventricular hypothalamic nucleus input to ventral of lateral septal nucleus controls chronic visceral pain.
    Pain. 2022 Aug 19. pii: 00006396-990000000-00158.
    PubMed    
    Abstract available

  97. YANG Y, Zhang S, Babygirija R, Shi B, et al
    Intranasal administration of Neuropeptide Y significantly antagonized stress-induced colonic dysmotility via central GABAA receptors in male rats.
    Am J Physiol Regul Integr Comp Physiol. 2022.
    PubMed    
    Abstract available

  98. VAN MALDEREN K, Hanning N, Lambrechts H, Haverhals T, et al
    Volatile organic compound profiling as a potential biomarker in irritable bowel syndrome: A feasibility study.
    Front Med (Lausanne). 2022;9:960000.
    PubMed    
    Abstract available

  99. WU S, Yuan C, Yang Z, Liu S, et al
    Non-alcoholic fatty liver is associated with increased risk of irritable bowel syndrome: a prospective cohort study.
    BMC Med. 2022;20:262.
    PubMed    
    Abstract available

  100. PATEL SM, Young MC
    The Identification and Management of Small Intestinal Bacterial Overgrowth: A Functional Medicine Approach.
    Phys Med Rehabil Clin N Am. 2022;33:587-603.
    PubMed    
    Abstract available

  101. PENG J, Lu Y, Chen L, Qiu K, et al
    The prognostic value of machine learning techniques versus cox regression model for head and neck cancer.
    Methods. 2022;205:123-132.
    PubMed    
    Abstract available

  102. INGROSSO MR, Ianiro G, Nee J, Lembo AJ, et al
    Systematic review and meta-analysis: efficacy of peppermint oil in irritable bowel syndrome.
    Aliment Pharmacol Ther. 2022 Aug 9. doi: 10.1111/apt.17179.
    PubMed    
    Abstract available

  103. CASTRO TEJERA V, Ohman L, Aabakken L, Fellstrom B, et al
    Randomised clinical trial and meta-analysis: mesalazine treatment in irritable bowel syndrome-Effects on gastrointestinal symptoms and rectal biomarkers of immune activity.
    Aliment Pharmacol Ther. 2022 Aug 8. doi: 10.1111/apt.17182.
    PubMed    
    Abstract available

  104. GOODOORY VC, Ng CE, Black CJ, Ford AC, et al
    Editorial: work and activity impairment are important considerations to optimise treatment plans for irritable bowel syndrome. Authors' reply.
    Aliment Pharmacol Ther. 2022;56:894-895.
    PubMed    


  105. SHAH ED, Wechsler EV
    Editorial: work and activity impairment are important considerations to optimise treatment plans for irritable bowel syndrome.
    Aliment Pharmacol Ther. 2022;56:892-893.
    PubMed    


  106. FAIRBRASS KM, Hamlin PJ, Gracie DJ, Ford AC, et al
    Natural history and impact of irritable bowel syndrome-type symptoms in inflammatory bowel disease during 6 years of longitudinal follow-up.
    Aliment Pharmacol Ther. 2022 Aug 22. doi: 10.1111/apt.17193.
    PubMed    
    Abstract available

  107. HUANG Z, Lin Z, Lin C, Chu H, et al
    Transcutaneous Electrical Acustimulation Improves Irritable Bowel Syndrome with Constipation by Accelerating Colon Transit and Reducing Rectal Sensation via Autonomic Mechanisms.
    Am J Gastroenterol. 2022 Jun 17. pii: 00000434-990000000-00418.
    PubMed    
    Abstract available

  108. OLIVER D, Talley NJ
    In drug-refractory IBS, group CBT with interoceptive exposure improved symptoms and QoL at 13 wk.
    Ann Intern Med. 2022 Aug 2. doi: 10.7326/J22-0054.
    PubMed    
    Abstract available

  109. COX JF 3RD
    In IBS, a smartphone application for self-managing a FODMAP-lowering diet vs. otilonium bromide reduced symptoms at 8 wk.
    Ann Intern Med. 2022;175:JC91.
    PubMed    
    Abstract available

  110. NAKOV R, Velikova T, Dimitrova-Yurukova D, Snegarova V, et al
    Prevalence and Risk Factors of Gastroesophageal Reflux Disease in Bulgaria: an internet-based survey.
    Dig Dis. 2022 Aug 16. pii: 000526355. doi: 10.1159/000526355.
    PubMed    
    Abstract available

  111. AIT ABDELLAH S, Gal C, Laterza L, Velenza V, et al
    Effect of a multistrain probiotic on leaky gut in patients with diarrhea-predominant irritable bowel syndrome (IBS-D): a pilot study.
    Dig Dis. 2022 Aug 25. pii: 000526712. doi: 10.1159/000526712.
    PubMed    
    Abstract available

  112. HOU Y, Dong L, Lu X, Shi H, et al
    Distinctions Between Fecal and Intestinal Mucosal Microbiota in Subgroups of Irritable Bowel Syndrome.
    Dig Dis Sci. 2022 Jul 25. pii: 10.1007/s10620-022-07588.
    PubMed    
    Abstract available

  113. GRABAUSKAS G, Gao J, Wu X, Zhou SY, et al
    Gut Microbiota Alter Visceral Pain Sensation and Inflammation via Modulation of Synthesis of Resolvin D1 in Colonic Tuft Cells.
    Gastroenterology. 2022 Aug 4. pii: S0016-5085(22)00829.
    PubMed    
    Abstract available

  114. CAMILLERI M
    Fifty-point IBS-SSS responders but persistence of moderate severity IBS in over 40% of those on diet.
    Gut. 2022 Jul 26. pii: gutjnl-2022-328211. doi: 10.1136/gutjnl-2022-328211.
    PubMed    


  115. TANAKA Y, Yamashita R, Kawashima J, Mori H, et al
    Omics profiles of fecal and oral microbiota change in irritable bowel syndrome patients with diarrhea and symptom exacerbation.
    J Gastroenterol. 2022 Jul 30. pii: 10.1007/s00535-022-01888.
    PubMed    
    Abstract available

  116. LI X, Ren K, Hong X, Guo S, et al
    Ameliorating Effects of Electroacupuncture on the Low-grade Intestinal Inflammation in Rat Model of Diarrhea-predominant Irritable Bowel Syndrome.
    J Gastroenterol Hepatol. 2022 Aug 12. doi: 10.1111/jgh.15981.
    PubMed    
    Abstract available

  117. RIZVI SA, Oriala C, Thomas J, Li S, et al
    Identifying Mast Cells in Gastrointestinal Biopsies in Pediatric Irritable Bowel Patients.
    J Pediatr Gastroenterol Nutr. 2022 Aug 17. pii: 00005176-990000000-00147.
    PubMed    
    Abstract available

  118. SLOMSKI A
    Durable IBS Response From Fecal Microbiota Transplant.
    JAMA. 2022;328:322.
    PubMed    


  119. YAN X, Wang J, Bai Y
    Potentials of circSOBP in the diagnosis and prognosis of gastric cancer.
    Scand J Gastroenterol. 2022 Aug 20:1-5. doi: 10.1080/00365521.2022.2088246.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;